Literature DB >> 20111044

Aldosterone 'escape' vs 'breakthrough'.

Robert W Schrier.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20111044     DOI： 10.1038/nrneph.2009.228

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  3 in total

Review 1.  The incidence and implications of aldosterone breakthrough.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Nat Clin Pract Nephrol       Date:  2007-09

2.  Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin.

Authors:  Genevieve Nguyen; Françoise Delarue; Céline Burcklé; Latifa Bouzhir; Thomas Giller; Jean-Daniel Sraer
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

Review 3.  Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism.

Authors:  Carolina R C Doorenbos; Jacob van den Born; Gerjan Navis; Martin H de Borst
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314
  3 in total
  27 in total

Review 1.  Aldosterone Production and Signaling Dysregulation in Obesity.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

2.  Dual blockade of the renin-angiotensin system with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs).

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

Review 3.  Distal convoluted tubule.

Authors:  James A McCormick; David H Ellison
Journal:  Compr Physiol       Date:  2015-01       Impact factor: 9.090

Review 4.  Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.

Authors:  Jozine M ter Maaten; Mattia A E Valente; Kevin Damman; Hans L Hillege; Gerjan Navis; Adriaan A Voors
Journal:  Nat Rev Cardiol       Date:  2015-01-06       Impact factor: 32.419

5.  Increased Spironolactone in Advanced Heart Failure: Effect of Doses Greater than 25 mg/Day on Plasma Potassium Concentration.

Authors:  Dmitry Shchekochikhin; JoAnn Lindenfeld; Robert Schrier
Journal:  Cardiorenal Med       Date:  2013-01-30       Impact factor: 2.041

Review 6.  Diuretic Treatment in Heart Failure.

Authors:  David H Ellison; G Michael Felker
Journal:  N Engl J Med       Date:  2017-11-16       Impact factor: 91.245

Review 7.  Neurohormonal activation in heart failure with reduced ejection fraction.

Authors:  Justin Hartupee; Douglas L Mann
Journal:  Nat Rev Cardiol       Date:  2016-10-06       Impact factor: 32.419

8.  Purinergic inhibition of ENaC produces aldosterone escape.

Authors:  James D Stockand; Elena Mironova; Vladislav Bugaj; Timo Rieg; Paul A Insel; Volker Vallon; Janos Peti-Peterdi; Oleh Pochynyuk
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

9.  Comparative efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a network meta-analysis of randomized controlled trials.

Authors:  Pingping Yang; Wen Shen; Xi Chen; Dan Zhu; Xiuxiu Xu; Tao Wu; Gaosi Xu; Qinghua Wu
Journal:  Heart Fail Rev       Date:  2019-09       Impact factor: 4.214

Review 10.  Aldosterone is associated with left ventricular hypertrophy in hemodialysis patients.

Authors:  Greicy Mara Mengue Feniman De Stefano; Silméia Garcia Zanati-Basan; Laercio Martins De Stefano; Viviana Rugolo Oliveira E Silva; Patrícia Santi Xavier; Pasqual Barretti; Roberto Jorge da Silva Franco; Jacqueline Costa Teixeira Caramori; Luis Cuadrado Martin
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.